ILJIN SNT Co., Ltd. 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 9:40 pm Sale | 2025-08-11 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 6,535,141 5.000% | -1,004,750 (-13.33%) | Filing |
| 2024-03-20 5:23 pm Purchase | 2024-03-20 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 7,539,891 13.000% | 355,993 (+4.96%) | Filing |
| 2023-05-10 4:30 pm Unchanged | 2023-05-10 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 7,183,898 13.000% | 0 (Unchanged) | Filing |
| 2023-01-20 4:30 pm Unchanged | 2023-01-19 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 7,183,898 13.000% | 0 (Unchanged) | Filing |
| 2023-01-06 4:30 pm Sale | 2023-01-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 7,183,898 13.000% | -1,093,902 (-13.21%) | Filing |
| 2022-03-03 4:15 pm Sale | 2022-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 8,277,800 13.000% | -717,639 (-7.98%) | Filing |
| 2021-01-27 4:14 pm Sale | 2021-01-25 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 8,995,439 7.100% | -1,536,675 (-14.59%) | Filing |
| 2021-01-26 4:06 pm Sale | 2021-01-22 | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co., Ltd. | 10,532,114 8.300% | -1,237,922 (-10.52%) | Filing |